HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Silvia Sabattini Selected Research
Silvia Sabattini Research Topics
Disease
15
Neoplasms (Cancer)
12/2023 - 01/2014
8
Neoplasm Metastasis (Metastasis)
06/2023 - 12/2018
4
Osteosarcoma (Osteogenic Sarcoma)
03/2023 - 12/2020
3
Hemangiosarcoma (Angiosarcoma)
08/2023 - 12/2019
3
Lymphoma (Lymphomas)
09/2021 - 01/2019
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 10/2010
2
Histiocytic Sarcoma
12/2021 - 12/2020
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2019
2
Stomatitis
12/2020 - 01/2020
1
Brain Neoplasms (Brain Tumor)
12/2023
1
Transitional Cell Carcinoma
07/2023
1
Inflammation (Inflammations)
01/2021
1
Pain (Aches)
01/2021
1
Pathologic Complete Response
01/2021
1
Carcinogenesis
12/2020
1
Hepatocellular Carcinoma (Hepatoma)
05/2020
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1
Squamous Cell Carcinoma of Head and Neck
01/2019
1
Sarcoma (Soft Tissue Sarcoma)
01/2019
1
Infections
01/2016
1
Carcinoma (Carcinomatosis)
05/2015
1
Stomach Neoplasms (Stomach Cancer)
01/2014
1
Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2014
Drug/Important Bio-Agent (IBA)
3
thiamine triphosphorate (TTP)
IBA
08/2023 - 01/2019
3
Vaccines
IBA
08/2023 - 01/2019
2
Peptides (Polypeptides)
IBA
08/2023 - 03/2022
2
Connexin 43 (Connexin43)
IBA
08/2023 - 03/2022
2
1- cyclohexyl- 3- (2- (4- morpholinyl)ethyl)carbodiimide
IBA
06/2023 - 12/2018
2
Biomarkers (Surrogate Marker)
IBA
12/2020 - 01/2016
2
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 01/2016
2
ErbB Receptors (EGF Receptor)
IBA
01/2014 - 10/2010
1
MicroRNAs (MicroRNA)
IBA
12/2023
1
Tensins
IBA
12/2023
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
12/2023
1
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2023
1
Cyclooxygenase Inhibitors
IBA
07/2023
1
Vinblastine (Vinblastine Sulfate)
FDA Link
01/2023
1
Coloring Agents (Dyes)
IBA
01/2022
1
Cannabinoids
IBA
01/2021
1
Endocannabinoids
IBA
01/2021
1
Platelet-Derived Growth Factor
IBA
12/2020
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2020
1
Sorafenib (BAY 43-9006)
FDA Link
05/2020
1
Anthracyclines
IBA
12/2019
1
Smoke
IBA
01/2019
1
Chromatin
IBA
01/2019
1
Tumor Suppressor Protein p53
IBA
01/2019
1
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
01/2016
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
05/2015
1
firocoxib
IBA
05/2015
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2014
1
Codon (Codons)
IBA
01/2014
Therapy/Procedure
6
Drug Therapy (Chemotherapy)
08/2023 - 01/2019
4
Surgical Amputation (Amputations)
03/2022 - 01/2021
3
Adjuvant Chemotherapy
03/2023 - 10/2021
3
Lymph Node Excision (Lymph Node Dissection)
01/2022 - 09/2021
3
Therapeutics
01/2021 - 01/2014
3
Radiotherapy
12/2020 - 05/2015
2
Splenectomy
03/2023 - 12/2019
2
Immunotherapy
01/2021 - 01/2019
1
Cutaneous Administration
03/2022
1
Anesthesia
01/2021
1
CHOP protocol (VDCP protocol)
01/2019